HCA Holdings Inc. buy UBS Group AG
Start price
14.08.24
/
50%
€337.30
Target price
14.08.25
€396.96
Performance (%)
0.33%
End price
15.08.25
€338.40
Summary
This prediction ended on 15.08.25 with a price of €338.40. During the runtime of the prediction for HCA Holdings Inc. the price only changed by 0.33%. UBS_Group_AG has a follow-up prediction for HCA Holdings Inc. where he still thinks HCA Holdings Inc. is a Buy. Dividends of €1.94 are taken into consideration when calculating the performance. UBS_Group_AG has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| HCA Holdings Inc. | -0.200% | -0.200% | 51.863% |
| iShares Core DAX® | -0,38 % | 2,61 % | 11,34 % |
| iShares Nasdaq 100 | -0,41 % | -2,00 % | 5,35 % |
| iShares Nikkei 225® | 1,84 % | 9,39 % | 33,53 % |
| iShares S&P 500 | -0,71 % | -0,48 % | 2,51 % |
Comments by UBS_Group_AG for this prediction
In the thread HCA Holdings Inc. diskutieren
HCA Healthcare, Inc. (NYSE: HCA) had its price target raised by analysts at UBS Group AG from $405.00 to $438.00. They now have a "buy" rating on the stock.
Ratings data for HCA provided by MarketBeat
In the thread Trading HCA Holdings Inc.
Die von UBS_Group_AG gewählte maximale Laufzeit wurde überschritten